Epic Research Update : Sequent Scientific

Sequent Scientific has received board’s approval for investment of up to Rs 150 crore in the equity capital/ convertible warrants of Shasun Pharmaceuticals. The investment is subject to statutory and other approvals, as may be applicable, including approval of shareholders under section 186 of the Companies Act, 2013.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips